
Aktiviere Job-Benachrichtigungen per E-Mail!
Erstelle in nur wenigen Minuten einen maßgeschneiderten Lebenslauf
Überzeuge Recruiter und verdiene mehr Geld. Mehr erfahren
Eine führende Forschungseinrichtung in Bayern sucht einen hochmotivierten PhD-Kandidaten (m/w/d) im Bereich Neuroimmunologie. Die Position bietet die Möglichkeit, translational zu forschen und innovative Methoden in der molekularen Biologie anzuwenden. Ideale Kandidaten haben einen Masterabschluss in einem relevanten Bereich und Erfahrung in molekularbiologischen Techniken. Wir bieten ein strukturiertes Arbeitsumfeld und umfassende Entwicklungsmöglichkeiten.
Klingt spannend?
The research group of Prof. Dr. Simone Mader, Head of the new Department of Translational Immunology is looking for a highly motivated PhD candidate (f/m/d) (TV-L E13 65%, initially limited to three years). We aim to elucidate how the immune system contributes to inflammation in the central nervous system and other immunologically affected tissues, with a particular focus on the role of autoantibodies and autoreactive B cells. Using advanced and innovative analytical approaches, we investigate both autoimmunity to known target antigens and the identification of previously unrecognized autoantigens across different autoimmune diseases. Building on these findings, this PhD project will explore candidate autoantigens and autoantibody-producing B cells, and understand possible triggers of autoimmunity.
The project will utilize cutting‑edge analytical methods in molecular biology, imaging, and neuroimmunology, offering the opportunity to conduct translational research with both in vitro models and patient‑derived samples. The PhD candidate (f/m/d) will be embedded in an interdisciplinary research environment at the intersection of neuroimmunology and rheumatology. The successful applicant is expected to present research outcomes through publications in peer‑reviewed journals and presentations at international scientific conferences.
Skills with microscopy imaging (confocal microscopy), flow cytometry, bioinformatics or generation of monoclonal antibodies would be advantageous.